Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 13;6(2):340-345.
doi: 10.1002/lio2.545. eCollection 2021 Apr.

Recurrent respiratory papillomatosis: A 2020 perspective

Jacob J Benedict  1 , Craig S Derkay  2
Affiliations
Review

Recurrent respiratory papillomatosis: A 2020 perspective

Jacob J Benedict et al. Laryngoscope Investig Otolaryngol. .

Abstract

Objective: Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a rare but challenging benign airway neoplasm. In recent years there has been significant shifts in incidence of this disease due to changes in vaccination and prevention for human papilloma virus (HPV) and its related pathology. This review will highlight the epidemiology, prevention and treatment of RRP.

Methods: The PubMed database was searched using relevant MeSH terms including "recurrent respiratory papillomatosis." The titles and abstracts were reviewed to assess relevance and unrelated articles were excluded. A full-text review for select articles was performed, the data and discussions were interpreted and synthesized to create a concise update on the management of RRP.

Results: With the increasing utilization of the 9-valent and quadrivalent HPV vaccine in Australia, we have seen a significant decrease in the incidence of RRP. Preliminary data in the US shows a similar trend of decreased incidence after implementation of vaccination. Single dose Gardasil in developing countries has shown sustained immunization for at least 7 years. Preliminary clinical trials and retrospective studies have shown the HPV vaccine may have benefit as a treatment method in addition to prevention for HPV related diseases. Bevacizumab (Avastin), a VEGF monoclonal antibody, has shown promise as a systemic treatment for RRP. The Corona Virus Disease 2019 (COVID-19) pandemic has affected perioperative management of RRP.

Conclusion: RRP continues to decline in incidence since the implementation of HPV vaccination. Advancement in the medical management including Bevacizumab show promise as an additional option for the management of RRP.

Keywords: Bevacizumab; HPV vaccine; human papilloma virus (HPV); recurrent respiratory papillomatosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial disclosures or conflict of interest.

References

    1. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008;118(7):1236‐1247. 10.1097/MLG.0b013e31816a7135. - DOI - PubMed
    1. Novakovic D, Cheng ATL, Zurynski Y, et al. A prospective study of the incidence of juvenile‐onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208‐212. 10.1093/infdis/jix498. - DOI - PubMed
    1. Sankaranarayanan R, Joshi S, Muwonge R, et al. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine. 2018;36(32, Part A):4783‐4791. 10.1016/j.vaccine.2018.02.087. - DOI - PubMed
    1. Murray ML, Meadows J, Doré CJ, et al. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC Med Res Methodol. 2018;18(1):125. 10.1186/s12874-018-0581-z. - DOI - PMC - PubMed
    1. Coskuner ER, Ozkan TA, Karakose A, Dillioglugil O, Cevik I. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study. J Sex Med. 2014;11(11):2785‐2791. 10.1111/jsm.12670. - DOI - PubMed

LinkOut - more resources